Ksilink : from patient to drug
  • PARTNERING
  • PLATFORM
    • Our approach
    • Our technology
    • Our science
  • PIPELINE
  • ABOUT US
    • Our Story
    • Our team
    • Our Scientific Committee
  • CORPORATE INFORMATION
    • News
    • Investors
    • Partners & Advisors
    • Ksilink Association
  • CONTACT US
Smarca2 in Cancer

Smarca2 in Cancer

by Ksil20@Nw-wsite | May 1, 2021

Therapeutic area: Oncology Disease: Non Small Cell Lung Cancers (NSCLC) / other cancers Monogenic inroad: Smarca 2 Cellular Model: Patient-derived cell line Project Origin: DKFZ, Prof. Nicolas Gunkel Medical need: SMARCA4 mutations have been identified in a high...

Video: Ksilink x 2CRSI

https://youtu.be/E22bSHpHGBo

Latest Post

  • Meet us at Conferences and Partnerings
  • New publication on phenotypic and transcriptomic characterization, and machine learning-based classification of desmin-related cardiomyopathy disease features
  • New publication on morphological map of under- and overexpression of genes in human cells
  • New publication on morphological profiling revealing neuroprotection in human dopaminergic neurons
  • We are thrilled to announce the arrival of our new Chief Operating Officer!

Categories

  • Conferences
  • Job Posting
  • Press releases
  • Publications
  • Short news
  • Unclassified
  • Video
Ksilink : from patient to drug

16 rue d’Ankara,
67000 Strasbourg
France

  • Our Approach
  • Technology
  • Pipeline
  • Gender Equality
  • Careers
  • Early Career Program
  • Privacy Policy
Contact us

contact@ksilink.com

Follow us on linkedin

2020 © ksilink. All rights reserved - Photo credit: Pierre Pommereau - Video credit: Mehdi Boswingel - Illustration credit: BioRender.com - Designed by Webdesign Consulting - Legal notices

Ksilink
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}